| VRTX | Vertex Pharmaceuticals Inc | $111.13B | +802800.69% |
| VRNA | Verona Pharma Plc | $77.75B | +561637.98% |
| REGN | Regeneron Pharmaceuticals Inc | $65.28B | +471594.70% |
| ARGX | Argen X SE | $54.32B | +392394.48% |
| ALNY | Alnylam Pharmaceuticals Inc | $39.13B | +282651.95% |
| ONC | BeiGene Ltd | $34.73B | +250848.51% |
| RVMD | Revolution Medicines Inc | $30.63B | +221187.56% |
| RPRX | Royalty Pharma plc - Class A | $23.57B | +170222.87% |
| BNTX | BioNTech SE | $23.52B | +169823.17% |
| INSM | Insmed Inc | $23.04B | +166352.83% |
| ROIV | Roivant Sciences Ltd | $21.31B | +153854.02% |
| INCY | Incyte Corp | $19.46B | +140523.25% |
| MRNA | Moderna Inc | $18.90B | +136464.10% |
| GMAB | Genmab | $17.06B | +123130.87% |
| ASND | Ascendis Pharma A/S | $15.18B | +109573.93% |
| JAZZ | Jazz Pharmaceuticals plc | $14.70B | +106145.81% |
| SMMT | Summit Therapeutics Inc | $13.47B | +97235.01% |
| BBIO | BridgeBio Pharma Inc | $13.00B | +93847.54% |
| EXEL | Exelixis Inc | $12.69B | +91606.59% |
| IONS | Ionis Pharmaceuticals Inc | $12.69B | +91586.27% |
| MDGL | Madrigal Pharmaceuticals Inc | $12.16B | +87747.39% |
| AXSM | Axsome Therapeutics Inc | $12.06B | +87029.17% |
| ARWR | Arrowhead Pharmaceuticals Inc | $11.10B | +80126.10% |
| ABVX | Abivax | $10.29B | +74221.28% |
| BMRN | Biomarin Pharmaceutical Inc | $10.12B | +73043.42% |
| PRAX | Praxis Precision Medicines Inc | $9.95B | +71786.56% |
| CYTK | Cytokinetics Inc | $9.51B | +68615.03% |
| KRYS | Krystal Biotech Inc | $9.03B | +65116.28% |
| NUVL | Nuvalent Inc - Class A | $8.45B | +60935.49% |
| IBRX | ImmunityBio Inc | $8.26B | +59605.32% |
| HALO | Halozyme Therapeutics Inc | $8.14B | +58688.32% |
| TECH | Bio-Techne Corp | $7.53B | +54282.81% |
| PCVX | Vaxcyte Inc | $7.36B | +53098.54% |
| CORT | Corcept Therapeutics Inc | $6.96B | +50191.44% |
| MRUS | Merus N.V | $6.83B | +49216.71% |
| IMVT | Immunovant Inc | $6.81B | +49129.74% |
| KYMR | Kymera Therapeutics Inc | $6.71B | +48411.77% |
| ACLX | Arcellx Inc | $6.67B | +48062.44% |
| PTGX | Protagonist Therapeutics Inc | $6.56B | +47330.67% |
| CDTX | Cidara Therapeutics Inc | $6.49B | +46822.18% |
| CELC | Celcuity Inc | $6.48B | +46698.12% |
| RYTM | Rhythm Pharmaceuticals Inc | $6.26B | +45109.67% |
| CNTA | Centessa Pharmaceuticals plc | $6.15B | +44360.57% |
| SRRK | Scholar Rock Holding Corp | $6.03B | +43477.98% |
| TGTX | TG Therapeutics Inc | $6.00B | +43260.25% |
| TERN | Terns Pharmaceuticals Inc | $5.95B | +42872.34% |
| MIRM | Mirum Pharmaceuticals Inc | $5.93B | +42744.83% |
| COGT | Cogent Biosciences Inc | $5.89B | +42480.82% |
| PTCT | PTC Therapeutics Inc | $5.86B | +42213.78% |
| APGE | Apogee Therapeutics Inc | $5.82B | +41965.69% |
| SYRE | Spyre Therapeutics Inc | $5.72B | +41203.95% |
| BLTE | Belite Bio Inc | $5.59B | +40287.34% |
| CGON | Cg Oncology Inc | $5.35B | +38560.94% |
| LEGN | Legend Biotech Corp | $5.26B | +37939.73% |
| APLS | Apellis Pharmaceuticals Inc | $5.25B | +37822.59% |
| XENE | Xenon Pharmaceuticals Inc | $5.21B | +37528.96% |
| CRSP | CRISPR Therapeutics AG | $5.16B | +37178.36% |
| DNTH | Dianthus Therapeutics Inc | $4.73B | +34080.00% |
| LGND | Ligand Pharmaceuticals Inc - Class B | $4.72B | +34036.32% |
| FOLD | Amicus Therapeutics Inc | $4.50B | +32444.13% |
| TVTX | Travere Therapeutics Inc | $4.41B | +31786.12% |
| AKRO | Akero Therapeutics Inc | $4.38B | +31547.35% |
| CAI | Caris Life Sciences Inc - Class A | $4.35B | +31309.01% |
| NAMS | NewAmsterdam Pharma Company NV | $4.26B | +30711.14% |
| ERAS | Erasca Inc | $3.88B | +27903.02% |
| CRNX | Crinetics Pharmaceuticals Inc | $3.87B | +27893.92% |
| CPRX | Catalyst Pharmaceuticals Inc | $3.83B | +27548.68% |
| VKTX | Viking Therapeutics Inc | $3.67B | +26410.60% |
| ACAD | Acadia Pharmaceuticals Inc | $3.63B | +26093.52% |
| EWTX | Edgewise Therapeutics Inc | $3.60B | +25946.22% |
| TLX | Telix Pharmaceuticals Ltd | $3.30B | +23740.87% |
| BEAM | Beam Therapeutics Inc | $3.28B | +23572.81% |
| DNLI | Denali Therapeutics Inc | $3.21B | +23067.09% |
| RCUS | Arcus Biosciences Inc | $3.01B | +21635.00% |
| DYN | Dyne Therapeutics Inc | $3.00B | +21575.90% |
| ORKA | ARCA biopharma Inc | $2.91B | +20919.60% |
| TNGX | Tango Therapeutics Inc | $2.83B | +20367.41% |
| GPCR | Structure Therapeutics Inc | $2.81B | +20203.31% |
| SLNO | Soleno Therapeutics Inc | $2.74B | +19708.37% |
| RLAY | Relay Therapeutics Inc | $2.73B | +19626.82% |
| ALMS | Alumis Inc | $2.67B | +19171.91% |
| IRON | Disc Medicine Inc | $2.66B | +19149.05% |
| ARQT | Arcutis Biotherapeutics Inc | $2.64B | +19007.95% |
| TARS | Tarsus Pharmaceuticals Inc | $2.58B | +18568.82% |
| IDYA | Ideaya Biosciences Inc | $2.57B | +18486.22% |
| ELVN | Enliven Therapeutics Inc | $2.52B | +18117.83% |
| IMNM | Immunome Inc | $2.50B | +17978.95% |
| MLYS | Mineralys Therapeutics Inc | $2.47B | +17778.48% |
| VERA | Vera Therapeutics Inc - Class A | $2.45B | +17598.07% |
| ETNB | 89bio Inc | $2.34B | +16828.15% |
| RARE | Ultragenyx Pharmaceutical Inc | $2.30B | +16512.37% |
| DAWN | Day One Biopharmaceuticals Inc | $2.22B | +15919.77% |
| KOD | Kodiak Sciences Inc | $2.18B | +15658.40% |
| CLDX | Celldex Therapeutics Inc | $2.11B | +15122.76% |
| ZLAB | Zai Lab Ltd | $2.08B | +14892.40% |
| AUPH | Aurinia Pharmaceuticals Inc | $2.03B | +14582.85% |
| MESO | Mesoblast Ltd | $2.02B | +14481.52% |
| TYRA | Tyra Biosciences Inc | $1.97B | +14152.43% |
| SION | Sionna Therapeutics Inc | $1.96B | +14044.24% |
| STOK | Stoke Therapeutics Inc | $1.96B | +14042.97% |
| NBTX | Nanobiotix | $1.94B | +13892.94% |
| AAPG | Ascentage Pharma Group International | $1.93B | +13863.53% |
| PHVS | Pharvaris NV | $1.92B | +13805.17% |
| IOVA | Iovance Biotherapeutics Inc | $1.91B | +13732.77% |
| GLPG | Galapagos NV | $1.90B | +13615.30% |
| RAPP | Rapport Therapeutics Inc | $1.89B | +13547.42% |
| OCUL | Ocular Therapeutix Inc | $1.87B | +13406.58% |
| TRVI | Trevi Therapeutics Inc | $1.86B | +13306.58% |
| ADMA | Adma Biologics Inc | $1.84B | +13192.35% |
| NVAX | Novavax Inc | $1.82B | +13074.70% |
| ZYME | Zymeworks BC Inc | $1.81B | +12993.56% |
| NRIX | Nurix Therapeutics Inc | $1.81B | +12951.50% |
| HRMY | Harmony Biosciences Holdings Inc | $1.78B | +12760.80% |
| VRDN | Viridian Therapeutics Inc | $1.77B | +12677.18% |
| SRPT | Sarepta Therapeutics Inc | $1.76B | +12622.99% |
| VCEL | Vericel Corp | $1.75B | +12530.41% |
| OCS | Oculis Holding AG | $1.74B | +12502.03% |
| SNDX | Syndax Pharmaceuticals Inc | $1.74B | +12445.39% |
| BHVN | Biohaven Ltd | $1.70B | +12177.13% |
| AGIO | Agios Pharmaceuticals Inc | $1.70B | +12170.85% |
| RXRX | Recursion Pharmaceuticals Inc - Class A | $1.68B | +12053.40% |
| CAPR | Capricor Therapeutics Inc | $1.68B | +12040.80% |
| ANAB | AnaptysBio Inc | $1.67B | +12000.61% |
| PVLA | Palvella Therapeutics Inc | $1.66B | +11923.44% |
| ABCL | AbCellera Biologics Inc | $1.65B | +11846.55% |
| TSHA | Taysha Gene Therapies Inc | $1.65B | +11834.83% |
| NUVB | Nuvation Bio Inc - Class A | $1.64B | +11766.81% |
| INVA | Innoviva Inc | $1.63B | +11701.38% |
| NTLA | Intellia Therapeutics Inc | $1.62B | +11596.21% |
| NKTR | Nektar Therapeutics | $1.62B | +11588.43% |
| GLUE | Monte Rosa Therapeutics Inc | $1.62B | +11579.10% |
| QURE | uniQure N.V. | $1.59B | +11363.07% |
| ATAI | ATAI Life Sciences N.V. | $1.58B | +11310.21% |
| RAPT | RAPT Therapeutics Inc | $1.56B | +11203.05% |
| SLS | SELLAS Life Sciences Group Inc | $1.56B | +11141.16% |
| PGEN | Precigen Inc | $1.55B | +11113.53% |
| IMTX | Immatics N.V | $1.53B | +10980.56% |
| ARDX | Ardelyx Inc | $1.52B | +10909.90% |
| MBX | MBX Biosciences Inc | $1.52B | +10857.30% |
| INBX | Inhibrx Biosciences Inc | $1.50B | +10770.63% |
| VIR | Vir Biotechnology Inc | $1.47B | +10500.98% |
| IMCR | Immunocore Holdings plc | $1.45B | +10374.52% |
| URGN | UroGen Pharma Ltd | $1.43B | +10221.97% |
| BCAX | Bicara Therapeutics Inc | $1.41B | +10120.03% |
| GHRS | GH Research PLC | $1.39B | +9921.89% |
| KALV | KalVista Pharmaceuticals Inc | $1.37B | +9817.65% |
| SEPN | Septerna Inc | $1.34B | +9567.74% |
| MPLT | MapLight Therapeutics Inc | $1.34B | +9552.27% |
| MLTX | MoonLake Immunotherapeutics - Class A | $1.31B | +9380.49% |
| MAZE | Maze Therapeutics Inc | $1.30B | +9261.40% |
| FTRE | FORTE SOFTWARE INC | $1.27B | +9072.58% |
| AVBP | ArriVent BioPharma Inc | $1.24B | +8892.71% |
| TRML | Tourmaline Bio Inc | $1.24B | +8828.32% |
| WVE | Wave Life Sciences Ltd | $1.22B | +8710.51% |
| ZBIO | Zenas Biopharma Inc | $1.13B | +8053.71% |
| OLMA | Olema Pharmaceuticals Inc | $1.13B | +8046.15% |
| EYPT | EyePoint Pharmaceuticals Inc | $1.10B | +7834.98% |
| MNKD | Mannkind Corp | $1.10B | +7823.27% |
| DBVT | DBV Technologies | $1.10B | +7814.14% |
| CRVS | Corvus Pharmaceuticals Inc | $1.09B | +7755.85% |
| SVRA | Savara Inc | $1.07B | +7613.91% |
| JBIO | Jade Biosciences Inc | $1.06B | +7565.46% |
| CVAC | CureVac N.V. | $1.05B | +7481.41% |
| ANNX | Annexon Inc | $1.05B | +7462.86% |
| VTYX | Ventyx Biosciences Inc | $998.72M | +7115.90% |
| GRCL | Gracell Biotechnologies Inc | $989.87M | +7051.95% |
| CGEM | Cullinan Oncology Inc | $953.73M | +6790.82% |
| PHAR | Pharming Group N.V. | $940.58M | +6695.87% |
| LXRX | Lexicon Pharmaceuticals Inc | $923.79M | +6574.52% |
| ABUS | Arbutus Biopharma Corp | $913.84M | +6502.63% |
| KURA | Kura Oncology Inc | $908.93M | +6467.19% |
| DRTS | Alpha Tau Medical Ltd | $905.62M | +6443.26% |
| ORIC | ORIC Pharmaceuticals Inc | $887.91M | +6315.32% |
| JANX | Janux Therapeutics Inc | $878.90M | +6250.18% |
| XNCR | Xencor Inc | $868.03M | +6171.66% |
| PHAT | Phathom Pharmaceuticals Inc | $853.21M | +6064.59% |
| SPRY | ARS Pharmaceuticals Inc | $844.05M | +5998.41% |
| GERN | Geron Corp | $843.41M | +5993.80% |
| EVMN | Evommune Inc | $841.03M | +5976.57% |
| VOR | Vor Biopharma Inc | $840.96M | +5976.08% |
| TBPH | Theravance Biopharma Inc | $837.63M | +5952.04% |
| DRUG | Bright Minds Biosciences Inc | $834.70M | +5930.85% |
| SANA | Sana Biotechnology Inc | $825.64M | +5865.39% |
| MGTX | MeiraGTx Holdings plc | $805.50M | +5719.89% |
| LBRX | LB Pharmaceuticals Inc | $797.16M | +5659.62% |
| OMER | Omeros Corporation | $797.02M | +5658.64% |
| ABSI | Absci Corp | $789.28M | +5602.70% |
| CMRX | Chimerix Inc | $766.03M | +5434.69% |
| RLMD | Relmada Therapeutics Inc | $761.50M | +5401.99% |
| ANRO | Alto Neuroscience Inc | $714.55M | +5062.74% |
| ATXS | Astria Therapeutics Inc | $709.95M | +5029.51% |
| DSGN | Design Therapeutics Inc | $693.10M | +4907.76% |
| SLDB | Solid Biosciences Inc | $690.73M | +4890.65% |
| BBOT | BridgeBio Oncology Therapeutics Inc Com | $683.16M | +4835.93% |
| CTMX | CytomX Therapeutics Inc | $675.41M | +4779.95% |
| CRMD | CorMedix Inc | $663.22M | +4691.91% |
| IVA | Inventiva | $655.21M | +4634.03% |
| ZVRA | Zevra Therapeutics Inc | $647.31M | +4576.91% |
| CABA | Cabaletta Bio Inc | $640.38M | +4526.88% |
| ACRS | Aclaris Therapeutics Inc | $639.61M | +4521.29% |
| PRME | Prime Medicine Inc | $596.03M | +4206.42% |
| CADL | Candel Therapeutics Inc | $589.73M | +4160.87% |
| CBIO | Crescent Biopharma Inc | $573.22M | +4041.61% |
| TECX | AvroBio Inc | $573.01M | +4040.09% |
| CLYM | Eliem Therapeutics Inc | $571.31M | +4027.82% |
| ARVN | Arvinas Inc | $570.83M | +4024.31% |
| ALLO | Allogene Therapeutics Inc | $550.84M | +3879.89% |
| VALN | Valneva SE | $545.52M | +3841.49% |
| RIGL | Rigel Pharmaceuticals | $542.79M | +3821.72% |
| GYRE | Gyre Therapeutics Inc | $540.72M | +3806.76% |
| DNA | Ginkgo Bioworks Holdings Inc - Class A | $538.30M | +3789.30% |
| MDXG | Mimedx Group Inc | $537.64M | +3784.55% |
| PRTA | Prothena Corporation plc | $532.36M | +3746.42% |
| KYTX | Kyverna Therapeutics Inc | $519.97M | +3656.90% |
| CTNM | Contineum Therapeutics Inc - Class A | $501.84M | +3525.85% |
| XOMA | XOMA Corp | $497.12M | +3491.76% |
| STRO | Sutro Biopharma Inc | $491.87M | +3453.83% |
| OCGN | Ocugen Inc | $466.88M | +3273.29% |
| SVA | Sinovac Biotech Ltd | $464.94M | +3259.26% |
| IMMX | Immix Biopharma Inc | $462.80M | +3243.77% |
| FDMT | 4D Molecular Therapeutics Inc | $462.60M | +3242.39% |
| STTK | Shattuck Labs Inc | $458.03M | +3209.31% |
| FULC | Fulcrum Therapeutics Inc | $451.60M | +3162.91% |
| MRVI | Maravai LifeSciences Holdings Inc - Class A | $451.41M | +3161.52% |
| UPB | Upstream Bio Inc | $449.51M | +3147.78% |
| AUTL | Autolus Therapeutics plc | $447.12M | +3130.52% |
| ADCT | Adc Therapeutics SA | $438.08M | +3065.23% |
| ASMB | Assembly Biosciences Inc | $435.45M | +3046.20% |
| MNPR | Monopar Therapeutics Inc | $432.42M | +3024.34% |
| AURA | Aura Biosciences Inc | $430.49M | +3010.36% |
| OVID | Ovid Therapeutics Inc | $424.86M | +2969.66% |
| NGNE | Neoleukin Therapeutics Inc | $419.60M | +2931.65% |
| IPSC | Century Therapeutics Inc | $415.14M | +2899.43% |
| ZURA | Zura Bio Ltd - Class A | $408.94M | +2854.63% |
| CMPX | Compass Therapeutics Inc | $408.80M | +2853.65% |
| CYBN | Cybin Inc | $408.43M | +2850.99% |
| AVTX | Avalo Therapeutics Inc | $403.76M | +2817.26% |
| GLSI | Greenwich LifeSciences Inc | $403.22M | +2813.30% |
| BNTC | Benitec Biopharma Inc | $398.51M | +2779.30% |
| LYEL | Lyell Immunopharma Inc | $390.28M | +2719.87% |
| YMAB | Y-Mabs Therapeutics Inc | $390.19M | +2719.17% |
| CCCC | C4 Therapeutics Inc | $389.10M | +2711.28% |
| VNDA | Vanda Pharmaceuticals Inc | $388.47M | +2706.78% |
| ENTA | Enanta Pharmaceuticals Inc | $383.31M | +2669.51% |
| RVNC | Revance Therapeutics Inc | $380.38M | +2648.29% |
| XFOR | X4 Pharmaceuticals Inc | $380.11M | +2646.35% |
| LXEO | Lexeo Therapeutics Inc | $377.10M | +2624.62% |
| PRTC | PureTech Health plc American Depositary Shares | $376.98M | +2623.77% |
| OABI | OmniAb Inc | $374.99M | +2609.37% |
| REPL | Replimune Group Inc | $374.27M | +2604.14% |
| ALT | Altimmune Inc | $373.67M | +2599.86% |
| VSTM | Verastem Inc | $373.33M | +2597.39% |
| EPRX | Eupraxia Pharmaceuticals Inc | $372.92M | +2594.43% |
| PBYI | Puma Biotechnology Inc | $371.93M | +2587.23% |
| LRMR | Larimar Therapeutics Inc | $365.67M | +2542.01% |
| CLLS | Cellectis | $364.91M | +2536.56% |
| AVIR | Atea Pharmaceuticals Inc | $364.12M | +2530.85% |
| EDIT | Editas Medicine Inc | $349.39M | +2424.37% |
| PALI | Palisade Bio Inc | $346.56M | +2403.97% |
| RGNX | Regenxbio Inc | $345.32M | +2394.98% |
| IMRX | Immuneering Corp Class A | $344.95M | +2392.36% |
| FENC | Fennec Pharmaceuticals Inc | $344.37M | +2388.16% |
| PRLD | Prelude Therapeutics Inc | $343.28M | +2380.28% |
| FBRX | Forte Biosciences Inc | $340.15M | +2357.66% |
| IMAB | I-Mab | $339.64M | +2353.93% |
| NMRA | Neumora Therapeutics Inc | $334.56M | +2317.27% |
| DMAC | DiaMedica Therapeutics Inc | $328.69M | +2274.83% |
| LCTX | Lineage Cell Therapeutics Inc | $326.58M | +2259.60% |
| RCKT | Rocket Pharmaceuticals Inc | $326.28M | +2257.43% |
| NAUT | Nautilus Biotechnology Inc | $325.30M | +2250.35% |
| ABEO | Abeona Therapeutics Inc | $323.57M | +2237.84% |
| SLN | Silence Therapeutics Plc | $321.20M | +2220.69% |
| RZLT | Rezolute Inc | $319.69M | +2209.82% |
| IVVD | Invivyd Inc | $319.57M | +2208.93% |
| BCYC | Bicycle Therapeutics Plc | $318.56M | +2201.66% |
| ANL | Adlai Nortye Ltd | $317.46M | +2193.67% |
| VTVT | vTv Therapeutics Inc - Class A | $305.06M | +2104.11% |
| SCPH | scPharmaceuticals Inc | $304.59M | +2100.72% |
| NAGE | Niagen Bioscience Inc | $304.32M | +2098.76% |
| SRZN | Surrozen Inc | $304.03M | +2096.63% |
| ARTV | Artiva Biotherapeutics Inc | $302.86M | +2088.23% |
| ELDN | Eledon Pharmaceuticals Inc | $295.82M | +2037.36% |
| IRD | Ocuphire Pharma Inc | $295.61M | +2035.80% |
| ARMP | Armata Pharmaceuticals Inc | $289.32M | +1990.38% |
| ACIU | AC Immune SA | $289.11M | +1988.89% |
| TENX | Tenax Therapeutics Inc | $288.39M | +1983.69% |
| ZNTL | Zentalis Pharmaceuticals Inc | $286.05M | +1966.74% |
| YDES | YD Bio Ltd | $278.91M | +1915.17% |
| MGNX | Macrogenics Inc | $278.39M | +1911.44% |
| FATE | Fate Therapeutics Inc | $275.57M | +1891.01% |
| CNTX | Context Therapeutics Inc | $273.80M | +1878.25% |
| SABS | SAB Biotherapeutics Inc | $272.68M | +1870.16% |
| NVCT | Nuvectis Pharma Inc | $269.23M | +1845.26% |
| ALXO | Alx Oncology Holdings Inc | $263.70M | +1805.28% |
| TARA | Protara Therapeutics Inc | $262.06M | +1793.46% |
| CGEN | Compugen Ltd | $260.97M | +1785.53% |
| TRDA | Entrada Therapeutics Inc | $257.38M | +1759.62% |
| CHRS | Coherus Biosciences Inc | $256.00M | +1749.65% |
| AVXL | Anavex Life Sciences Corporation | $255.77M | +1748.01% |
| HUMA | Humacyte Inc | $255.32M | +1744.74% |
| FHTX | Foghorn Therapeutics Inc | $250.69M | +1711.30% |
| ALEC | Alector Inc | $245.37M | +1672.81% |
| LENZ | LENZ Therapeutics Inc | $242.37M | +1651.16% |
| THRD | Third Harmonic Bio Inc | $241.86M | +1647.51% |
| CDXS | Codexis Inc | $239.96M | +1633.75% |
| VYGR | Voyager Therapeutics Inc | $237.02M | +1612.51% |
| ADAG | Adagene Inc | $236.93M | +1611.84% |
| NKTX | Nkarta Inc | $236.88M | +1611.52% |
| GNFT | GENFIT S.A. American Depositary Shares | $233.01M | +1583.55% |
| OBIO | Orchestra BioMed Holdings Inc | $231.59M | +1573.29% |
| NERV | Minerva Neurosciences Inc | $230.61M | +1566.19% |
| SLRN | Acelyrin Inc | $228.54M | +1551.27% |
| WHWK | Whitehawk Therapeutics Inc | $225.60M | +1529.99% |
| IKT | Inhibikase Therapeutics Inc | $224.46M | +1521.73% |
| CRBU | Caribou Biosciences Inc | $223.96M | +1518.13% |
| KROS | Keros Therapeutics Inc | $223.18M | +1512.50% |
| RNA | Atrium Therapeutics Inc | $222.37M | +1506.68% |
| CAMP | CAMP4 Therapeutics Corp | $218.61M | +1479.48% |
| ARCT | Arcturus Therapeutics Holdings Inc | $217.72M | +1473.06% |
| SLGL | Sol-Gel Technologies Ltd | $205.59M | +1385.43% |
| KPTI | Karyopharm Therapeutics Inc | $202.45M | +1362.70% |
| TLSA | Tiziana Life Sciences Ltd | $201.81M | +1358.08% |
| ELTX | Elicio Therapeutics Inc | $200.75M | +1350.46% |
| KRRO | Korro Bio Inc | $198.45M | +1333.87% |
| RNAC | Cartesian Therapeutics Inc | $197.81M | +1329.25% |
| DTIL | Precision Biosciences Inc | $195.87M | +1315.17% |
| IMUX | Immunic Inc | $190.70M | +1277.84% |
| QTTB | Q32 Bio Inc | $187.99M | +1258.25% |
| ENLV | Enlivex Therapeutics Ltd | $185.63M | +1241.22% |
| MDWD | MediWound Ltd | $184.49M | +1232.94% |
| ABOS | Acumen Pharmaceuticals Inc | $183.46M | +1225.51% |
| THAR | Tharimmune Inc | $183.00M | +1222.20% |
| IFRX | InflaRx N.V. | $182.18M | +1216.27% |
| SGMT | Sagimet Biosciences Inc - Class A | $180.81M | +1206.39% |
| UNCY | Unicycive Therapeutics Inc | $178.43M | +1189.19% |
| GALT | Galectin Therapeutics Inc | $177.81M | +1184.73% |
| ACHV | Achieve Life Sciences Inc | $173.54M | +1153.88% |
| CRBP | Corbus Pharmaceuticals Holdings Inc | $172.60M | +1147.06% |
| TNXP | Tonix Pharmaceuticals Holding Corp | $172.60M | +1147.03% |
| HRTX | Heron Therapeutics Inc | $172.54M | +1146.63% |
| TNYA | Tenaya Therapeutics Inc | $171.88M | +1141.90% |
| RANI | Rani Therapeutics Holdings Inc Class A | $171.00M | +1135.48% |
| SPRO | Spero Therapeutics Inc | $169.62M | +1125.55% |
| PLX | Protalix BioTherapeutics Inc | $169.28M | +1123.07% |
| THTX | Theratechnologies Inc | $167.34M | +1109.03% |
| ANTX | AN2 Therapeutics Inc | $166.61M | +1103.81% |
| EQ | Equillium Inc | $166.29M | +1101.44% |
| MIST | Milestone Pharmaceuticals Inc | $164.91M | +1091.52% |
| PRQR | ProQR Therapeutics N.V | $164.37M | +1087.57% |
| MENS | Jyong Biotech Ltd | $164.22M | +1086.52% |
| ORMP | Oramed Pharmaceuticals Inc | $162.89M | +1076.88% |
| IPHA | Innate Pharma | $159.97M | +1055.82% |
| TTRX | Turn Therapeutics Inc | $157.58M | +1038.53% |
| MOLN | Molecular Partners AG | $154.89M | +1019.07% |
| VXRT | Vaxart Inc | $153.61M | +1009.87% |
| HURA | TuHURA Biosciences Inc | $151.32M | +993.29% |
| NBP | NovaBridge Biosciences. | $150.91M | +990.36% |
| CNTB | Connect Biopharma Holdings Ltd | $150.51M | +987.45% |
| AKTX | Akari Therapeutics Plc | $148.12M | +970.22% |
| MRSN | Mersana Therapeutics Inc | $145.36M | +950.22% |
| INDP | Indaptus Therapeutics Inc | $143.82M | +939.11% |
| NRXP | NRX Pharmaceuticals Inc | $143.26M | +935.06% |
| PROK | ProKidney Corp - Class A | $137.85M | +895.99% |
| TCRX | Tscan Therapeutics Inc | $137.63M | +894.37% |
| GNLX | Genelux Corp | $137.21M | +891.38% |
| GUTS | Fractyl Health Inc | $136.31M | +884.87% |
| BDTX | Black Diamond Therapeutics Inc | $132.37M | +856.37% |
| AGEN | Agenus Inc | $131.36M | +849.09% |
| ACOG | Alpha Cognition Inc | $124.77M | +801.45% |
| CRDF | Cardiff Oncology Inc | $123.75M | +794.11% |
| KLRS | Kalaris Therapeutics Inc | $120.48M | +770.49% |
| NTHI | NeOnc Technologies Holdings Inc | $120.03M | +767.24% |
| SEER | Seer Inc - Class A | $115.64M | +735.53% |
| ENGN | enGene Holdings Inc | $115.22M | +732.50% |
| RPTX | Repare Therapeutics Inc | $113.91M | +723.03% |
| COYA | Coya Therapeutics Inc | $111.89M | +708.43% |
| PYXS | Pyxis Oncology Inc | $108.70M | +685.36% |
| VANI | Vivani Medical Inc | $108.35M | +682.84% |
| CGTX | Cognition Therapeutics Inc | $106.33M | +668.26% |
| HLVX | HilleVax Inc | $104.74M | +656.76% |
| ONCY | Oncolytics Biotech Inc | $104.52M | +655.14% |
| VRCA | Verrica Pharmaceuticals Inc | $104.10M | +652.16% |
| ALDX | Aldeyra Therapeutics Inc | $103.15M | +645.27% |
| PEPG | PepGen Inc | $103.13M | +645.12% |
| ADVM | Adverum Biotechnologies Inc | $102.40M | +639.88% |
| BMEA | Biomea Fusion Inc | $98.33M | +610.43% |
| CBUS | Cibus Global Ltd. Class A | $97.80M | +606.65% |
| KZIA | Kazia Therapeutics Ltd | $97.74M | +606.19% |
| ICCC | Immucell Corp | $96.17M | +594.83% |
| PMN | ProMIS Neurosciences Inc | $93.94M | +578.71% |
| ATHA | Athira Pharma Inc | $92.15M | +565.80% |
| FBIO | Fortress Biotech Inc | $91.60M | +561.79% |
| PTHS | Channel Therapeutics Corporation | $90.85M | +556.43% |
| ATRA | Atara Biotherapeutics Inc | $89.72M | +548.22% |
| ANIX | Anixa Biosciences Inc | $88.68M | +540.71% |
| EXOZ | Invizyne Technologies Inc | $88.10M | +536.51% |
| INO | Inovio Pharmaceuticals Inc | $87.22M | +530.15% |
| AARD | Aardvark Therapeutics Inc | $87.05M | +528.93% |
| ADAP | Adaptimmune Therapeutics plc American Depositary Shares | $86.99M | +528.52% |
| PYPD | Polypid Ltd | $86.83M | +527.38% |
| NRXS | Neuraxis Inc | $85.30M | +516.33% |
| LPTX | Leap Therapeutics Inc | $84.76M | +512.40% |
| CSBR | Champions Oncology Inc | $82.35M | +494.98% |
| ACET | Adicet Bio Inc | $81.58M | +489.43% |
| HYFT | MindWalk Holdings Corp | $79.54M | +474.70% |
| MAIA | MAIA Biotechnology Inc | $79.48M | +474.25% |
| SGMO | Sangamo Therapeutics Inc | $77.92M | +463.01% |
| FBIOP | Fortress Biotech Inc | $77.72M | +461.54% |
| RLYB | Rallybio Corp | $76.87M | +455.38% |
| PLRX | Pliant Therapeutics Inc | $76.77M | +454.71% |
| GANX | Gain Therapeutics Inc | $75.20M | +443.37% |
| LIXT | Lixte Biotechnology Holdings Inc | $74.68M | +439.60% |
| XBIT | XBiotech Inc | $74.39M | +437.48% |
| OSTX | OS Therapies Inc | $74.24M | +436.37% |
| MCRB | Seres Therapeutics Inc | $73.19M | +428.81% |
| SAVA | Cassava Sciences Inc. | $72.46M | +423.55% |
| MNMD | Mind Medicine (MindMed) Inc. Common Shares | $71.93M | +419.68% |
| EDSA | Edesa Biotech Inc | $70.82M | +411.68% |
| BYSI | BeyondSpring Inc | $70.31M | +408.04% |
| ATHE | Alterity Therapeutics Ltd | $68.71M | +396.46% |
| SPRB | Spruce Biosciences Inc | $67.96M | +390.99% |
| CUE | Cue Biopharma Inc | $66.52M | +380.64% |
| IMA | Ikena Oncology Inc | $66.48M | +380.35% |
| MNOV | Medicinova Inc | $65.46M | +372.99% |
| IBIO | iBio Inc | $64.94M | +369.22% |
| ACRV | Acrivon Therapeutics Inc | $64.32M | +364.70% |
| PMVP | PMV Pharmaceuticals Inc | $64.00M | +362.40% |
| IMMP | Immutep Ltd | $63.92M | +361.84% |
| KLTO | Klotho Neurosciences Inc Com | $63.55M | +359.18% |
| OKYO | OKYO Pharma Ltd - New | $63.24M | +356.93% |
| ACHL | Achilles Therapeutics Plc | $63.22M | +356.78% |
| PDSB | PDS Biotechnology Corporation | $61.96M | +347.64% |
| OTLK | Outlook Therapeutics Inc | $61.25M | +342.55% |
| GLTO | Galecto Inc | $60.81M | +339.36% |
| OKUR | Reneo Pharmaceuticals Inc - Class A | $59.20M | +327.73% |
| ANVS | Annovis Bio Inc | $57.22M | +313.40% |
| DWTX | Virios Therapeutics Inc | $57.12M | +312.68% |
| ENTX | Entera Bio Ltd | $55.48M | +300.86% |
| TIL | Instil Bio Inc | $55.21M | +298.87% |
| KZR | Kezar Life Sciences Inc | $53.76M | +288.42% |
| IBO | NYSE AMEX LISTED TEST STOCK FOR CTS CQS | $52.83M | +281.72% |
| MREO | Mereo Biopharma Group Plc | $52.71M | +280.84% |
| NBY | Stablecoin Development Corp | $52.10M | +276.42% |
| RNTX | Rein Therapeutics Inc | $51.79M | +274.22% |
| GOSS | Gossamer Bio Inc | $51.14M | +269.50% |
| MGX | Metagenomi Inc | $50.82M | +267.21% |
| ACTU | Actuate Therapeutics Inc | $50.03M | +261.49% |
| INKT | MiNK Therapeutics Inc | $48.84M | +252.89% |
| ESLA | Estrella Immunopharma Inc | $48.44M | +249.98% |
| XLO | Xilio Therapeutics Inc | $48.23M | +248.44% |
| CING | Cingulate Inc | $47.16M | +240.72% |
| ATYR | Atyr Pharma Inc | $46.89M | +238.77% |
| LVTX | LAVA Therapeutics NV | $45.77M | +230.70% |
| TELO | Telomir Pharmaceuticals Inc | $45.73M | +230.38% |
| PSTV | Plus Therapeutics Inc | $45.56M | +229.21% |
| ATOS | Atossa Therapeutics Inc | $44.09M | +218.56% |
| KALA | Kala Bio Inc | $43.31M | +212.95% |
| RNXT | RenovoRx Inc | $41.96M | +203.15% |
| NTRB | Nutriband Inc | $41.39M | +199.06% |
| HYPD | Eyenovia Inc | $41.14M | +197.26% |
| FGEN | FibroGen Inc | $39.31M | +183.99% |
| NNVC | NanoViricides Inc | $37.88M | +173.70% |
| VERU | Veru Inc | $37.40M | +170.20% |
| LTRN | Lantern Pharma Inc | $37.25M | +169.16% |
| INMB | INmune Bio Inc | $37.22M | +168.92% |
| ATNM | Actinium Pharmaceuticals Inc | $36.71M | +165.23% |
| RADX | Radiopharm Theranostics Ltd | $36.10M | +160.86% |
| GRCE | Acasti Pharma Inc | $36.05M | +160.50% |
| GBIO | Generation Bio Company | $35.97M | +159.88% |
| ABVC | ABVC BioPharma Inc | $35.82M | +158.78% |
| MURA | Mural Oncology plc | $35.34M | +155.36% |
| LITS | Lite Strategy Inc | $35.16M | +154.01% |
| ALGS | Aligos Therapeutics Inc | $34.65M | +150.38% |
| QNTM | FSD Pharma Inc - Class B - Class B (Sub Voting) | $34.30M | +147.82% |
| DARE | Dare Bioscience Inc | $33.92M | +145.10% |
| EVAX | Evaxion Biotech A/S | $33.82M | +144.35% |
| BOLD | Boundless Bio Inc | $32.94M | +137.98% |
| SNTI | Senti Biosciences Inc | $31.46M | +127.28% |
| TVRD | Cara Therapeutics Inc | $30.96M | +123.68% |
| LSTA | Lisata Therapeutics Inc | $30.05M | +117.15% |
| TVGN | Tevogen Bio Holdings Inc | $29.97M | +116.56% |
| APLM | Apollomics Inc - Class A | $29.93M | +116.25% |
| NRSN | NeuroSense Therapeutics Ltd | $29.15M | +110.60% |
| SKYE | Skye Bioscience Inc | $29.10M | +110.27% |
| NEUP | Neuphoria Therapeutics Inc | $29.04M | +109.80% |
| GRDX | Entero Therapeutics Inc | $28.95M | +109.19% |
| BRNS | Barinthus Biotherapeutics Plc. | $28.59M | +106.54% |
| CRVO | CervoMed Inc | $28.15M | +103.36% |
| IGC | IGC Pharma Inc | $28.00M | +102.30% |
| DYAI | Dyadic International Inc DE | $27.40M | +97.96% |
| ALLR | Allarity Therapeutics Inc | $27.37M | +97.73% |
| SER | AgeX Therapeutics Inc | $26.82M | +93.77% |
| PLRZ | Polyrizon Ltd | $26.52M | +91.61% |
| CELU | Celularity Inc - Class A | $26.39M | +90.67% |
| VTGN | VistaGen Therapeutics Inc | $26.36M | +90.44% |
| BCTX | BriaCell Therapeutics Corp - New | $26.32M | +90.16% |
| PTN | Palatin Technologies Inc | $26.08M | +88.40% |
| TPST | Tempest Therapeutics Inc | $25.68M | +85.51% |
| JSPR | Jasper Therapeutics Inc | $25.26M | +82.54% |
| PLUR | Pluri Inc | $24.62M | +77.86% |
| MRKR | Marker Therapeutics Inc | $24.21M | +74.96% |
| HOWL | Werewolf Therapeutics Inc | $23.81M | +72.05% |
| VYNE | VYNE Therapeutics Inc | $22.68M | +63.84% |
| SNSE | Sensei Biotherapeutics Inc | $22.32M | +61.24% |
| HOTH | Hoth Therapeutics Inc | $22.13M | +59.88% |
| COEP | Coeptis Therapeutics Holdings Inc. Common Stock | $21.96M | +58.63% |
| NXTC | Nextcure Inc | $21.90M | +58.22% |
| OPT | Opthea Ltd | $21.53M | +55.55% |
| CRIS | Curis Inc | $21.11M | +52.51% |
| PHXM | PHAXIAM Therapeutics SA ADR | $20.38M | +47.22% |
| LGVN | Longeveron Inc - Class A | $19.70M | +42.35% |
| GNTA | Genenta Science SpA | $19.23M | +38.91% |
| AEON | AEON Biopharma Inc - Class A | $19.22M | +38.89% |
| ANEB | Anebulo Pharmaceuticals, Inc. Common Stock | $18.90M | +36.55% |
| XCUR | Exicure Inc | $17.78M | +28.49% |
| INAB | IN8bio Inc | $17.72M | +28.06% |
| PASG | Passage Bio Inc | $17.71M | +27.94% |
| KTTA | Pasithea Therapeutics Corp | $17.28M | +24.86% |
| LPCN | Lipocine Inc | $17.04M | +23.14% |
| NCEL | NLS Pharmaceutics Ltd | $16.55M | +19.59% |
| OSRH | Bellevue Life Sciences Acquisition Corp | $16.12M | +16.45% |
| HIND | ReShape Lifesciences Inc | $15.72M | +13.59% |
| COCP | Cocrystal Pharma Inc | $15.44M | +11.57% |
| CTXR | Citius Pharmaceuticals Inc | $15.44M | +11.55% |
| LEXX | Lexaria Bioscience Corp | $15.24M | +10.10% |
| CLRB | Cellectar Biosciences Inc | $14.97M | +8.14% |
| QNCX | Quince Therapeutics Inc | $14.89M | +7.61% |
| APLT | Applied Therapeutics Inc | $14.86M | +7.39% |
| HOOK | Hookipa Pharma Inc | $14.68M | +6.05% |
| BLRX | Bioline Rx Ltd | $14.66M | +5.95% |
| MBRX | Moleculin Biotech Inc | $14.57M | +5.26% |
| IOBT | IO Biotech Inc | $14.50M | +4.75% |
| ICU | SeaStar Medical Holding Corp | $14.34M | +3.59% |
| GDTC | CytoMed Therapeutics Ltd | $14.15M | +2.21% |
| GTBP | GT Biopharma Inc | $13.91M | +0.48% |
| CMMB | Chemomab Therapeutics Ltd | $13.67M | -1.27% |
| TOVX | Theriva Biologics Inc | $13.51M | -2.42% |
| CYCN | Cyclerion Therapeutics Inc | $13.36M | -3.47% |
| LSB | LakeShore Biopharma Co Ltd | $13.02M | -5.92% |
| ERNA | Ernexa Therapeutics Inc | $12.99M | -6.15% |
| PHIO | Phio Pharmaceuticals Corp | $12.78M | -7.67% |
| CVKD | Cadrenal Therapeutics Inc | $12.33M | -10.89% |
| CALC | CalciMedica Inc | $11.72M | -15.29% |
| LNAI | Lunai Bioworks Inc | $11.72M | -15.35% |
| TRAW | Traws Pharma Inc | $11.70M | -15.48% |
| INTS | Intensity Therapeutics Inc | $11.33M | -18.13% |
| BIVI | BioVie Inc - Class A | $11.16M | -19.35% |
| KPRX | Kiora Pharmaceuticals Inc | $11.14M | -19.50% |
| BRTX | BioRestorative Therapies Inc | $11.03M | -20.31% |
| APRE | Aprea Therapeutics Inc | $10.96M | -20.82% |
| KAPA | Kairos Pharma Ltd | $10.68M | -22.80% |
| KLTOW | Klotho Neurosciences Inc Wt Exp | $10.43M | -24.67% |
| CVM | Cel-Sci Corp | $10.15M | -26.70% |
| BOLT | Bolt Biotherapeutics Inc | $10.13M | -26.83% |
| MLEC | Moolec Science SA | $10.06M | -27.33% |
| BCDA | BioCardia Inc | $9.85M | -28.83% |
| QNRX | Quoin Pharmaceuticals Ltd | $9.81M | -29.15% |
| CURX | Curanex Pharmaceuticals Inc | $9.73M | -29.71% |
| SNGX | Soligenix Inc | $9.11M | -34.21% |
| IMNN | Imunon Inc | $9.02M | -34.81% |
| EPIX | Essa Pharma Inc | $8.93M | -35.47% |
| SONN | Sonnet BioTherapeutics Holdings Inc | $8.92M | -35.57% |
| CANF | Can-Fite Biopharma Ltd | $8.80M | -36.43% |
| JUNS | Jupiter Neurosciences Inc | $8.70M | -37.11% |
| CELZ | Creative Medical Technology Holdings Inc | $8.54M | -38.30% |
| IMRN | Immuron Ltd | $8.36M | -39.61% |
| PMCB | PharmaCyte Biotech Inc | $8.16M | -41.05% |
| LIMN | Liminatus Pharma Inc | $8.08M | -41.64% |
| ITRM | Iterum Therapeutics Plc | $8.06M | -41.76% |
| NCNA | NuCana plc | $7.95M | -42.57% |
| ADXN | Addex Therapeutics Ltd | $7.90M | -42.93% |
| SYBX | Synlogic Inc | $7.72M | -44.21% |
| BCLI | Brainstorm Cell Therapeutics Inc | $7.66M | -44.62% |
| XTLB | X.T.L. Biopharmaceuticals Ltd | $7.34M | -47.00% |
| XBIO | Xenetic Biosciences Inc | $7.06M | -48.96% |
| GNPX | Genprex Inc | $7.02M | -49.27% |
| ASBP | Aspire Biopharma Holdings Inc | $6.98M | -49.56% |
| EVGN | Evogene Ltd | $6.91M | -50.04% |
| SILO | SILO Pharma Inc | $6.78M | -50.99% |
| ACXP | Acurx Pharmaceuticals Inc | $6.74M | -51.27% |
| TCRT | Alaunos Therapeutics Inc | $6.68M | -51.71% |
| PCSA | Processa Pharmaceuticals Inc | $6.40M | -53.76% |
| GOVX | Geovax Labs Inc | $6.29M | -54.59% |
| APM | Aptorum Group Ltd - Class A | $6.26M | -54.80% |
| BCAB | BioAtla Inc | $6.19M | -55.27% |
| PPBT | Purple Biotech Ltd | $6.05M | -56.29% |
| APVO | Aptevo Therapeutics Inc | $5.83M | -57.90% |
| BGMS | Bio Green Med Solution Inc | $5.30M | -61.72% |
| CLGN | CollPlant Biotechnologies Ltd New | $5.25M | -62.06% |
| DRMA | Dermata Therapeutics Inc | $5.23M | -62.22% |
| CDIO | Cardio Diagnostics Holdings Inc | $5.18M | -62.58% |
| HCWB | HCW Biologics Inc | $5.10M | -63.17% |
| PULM | Pulmatrix Inc | $4.97M | -64.11% |
| TTNP | Titan Pharmaceuticals Inc (de) | $4.91M | -64.53% |
| RVPH | Reviva Pharmaceuticals Holdings Inc | $4.91M | -64.56% |
| RNAZ | TransCode Therapeutics Inc | $4.67M | -66.28% |
| ALZN | Alzamend Neuro Inc | $4.38M | -68.39% |
| MBIO | Mustang Bio Inc | $4.29M | -69.00% |
| CASI | CASI Pharmaceuticals Inc | $4.27M | -69.18% |
| ENTO | Entero Therapeutics, Inc. Common Stock | $4.26M | -69.19% |
| REVB | Revelation Biosciences Inc | $4.26M | -69.22% |
| FBLG | FibroBiologics Inc | $4.23M | -69.47% |
| ENVB | Enveric Biosciences Inc | $4.15M | -70.00% |
| CNSP | Cns Pharmaceuticals Inc | $4.14M | -70.10% |
| GLMD | Galmed Pharmaceuticals Ltd | $4.08M | -70.52% |
| PHGE | BiomX Inc | $3.91M | -71.78% |
| PBM | Psyence Biomedical Ltd | $3.76M | -72.81% |
| SXTP | 60 Degrees Pharmaceuticals Inc | $3.72M | -73.14% |
| ADIL | Adial Pharmaceuticals Inc | $3.61M | -73.94% |
| VIVS | VivoSim Labs Inc | $3.36M | -75.69% |
| XRTX | XORTX Therapeutics Inc | $3.34M | -75.85% |
| AZTR | Azitra Inc | $3.32M | -76.00% |
| GRI | GRI Bio Inc | $3.30M | -76.18% |
| SPRC | SciSparc Ltd | $3.05M | -78.00% |
| AFMD | Affimed N.V. | $2.98M | -78.50% |
| CMND | Clearmind Medicine Inc | $2.88M | -79.18% |
| ENSC | Ensysce Biosciences Inc | $2.88M | -79.22% |
| ARTL | Artelo Biosciences Inc | $2.75M | -80.16% |
| OGEN | Oragenics Inc | $2.58M | -81.38% |
| PPCB | Propanc Biopharma Inc | $2.50M | -81.93% |
| NTBL | Notable Labs Inc Ord | $2.39M | -82.70% |
| BBLG | Bone Biologics Corp | $2.23M | -83.92% |
| CLSD | Clearside Biomedical, Inc. Common Stock | $2.15M | -84.50% |
| QLGN | Qualigen Therapeutics, Inc. Common Stock | $2.09M | -84.91% |
| CLDI | Calidi Biotherapeutics Inc | $1.99M | -85.59% |
| AIM | AIM ImmunoTech Inc. | $1.74M | -87.40% |
| ONCO | Onconetix Inc | $1.61M | -88.35% |
| ONCT | Oncternal Therapeutics Inc | $1.56M | -88.74% |
| ZVSA | ZyVersa Therapeutics Inc | $1.55M | -88.77% |
| SCNI | Scinai Immunotherapeutics Ltd | $1.55M | -88.78% |
| VRAX | Virax Biolabs Group Ltd - Class A | $1.52M | -89.02% |
| ABP | Abpro Holdings, Inc Common Stock | $1.43M | -89.69% |
| LYRA | Lyra Therapeutics Inc | $1.38M | -90.00% |
| JAGX | Jaguar Health Inc | $1.34M | -90.29% |
| SLXN | Silexion Therapeutics Corp | $1.30M | -90.60% |
| PTIX | Protagenic Therapeutics Inc | $1.01M | -92.72% |
| BDRX | Biodexa Pharmaceuticals Plc | $919907.57 | -93.35% |
| TNFA | TNF Pharmaceuticals Inc | $551031.39 | -96.02% |
| SLRX | Decoy Therapeutics Inc | $446853.12 | -96.77% |
| ELAB | PMGC Holdings Inc | $221376.00 | -98.40% |
| ADTX | Aditxt Inc | $132564.52 | -99.04% |
| CDT | CDT Equity Inc | $110551.31 | -99.20% |